Abstract: The present invention relates to a crystalline form of compound (I) and a method of making the crystalline form of compound (I). The invention also provides pharmaceutical compositions comprising the crystalline form of compound (I). Furthermore, the invention relates to methods of using this crystalline form of compound (I) as a medicament and in the treatment of a disease involving abnormal levels of glucosylceramide and/or higher levels of glycosphingolipids.
Type:
Grant
Filed:
October 1, 2021
Date of Patent:
October 15, 2024
Assignee:
Azafaros B.V.
Inventors:
Robert Hett, Fritz Blatter, Jennifer Robin, Kyle Landskroner